Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in VTRS — Viatris Inc

CIK 923093 STAMFORD, CT

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,731,597
+$1,758,733 QoQ
Shares Held
276,210
+74.3% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Mar 31, 2026
CallValue
$147,259
CallShares
10,900
PutValue
$174,279
PutShares
12,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $23,421,840 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (15.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 VTRS
Viatris Inc
This page
276,210 $3,731,597

All Filings in VTRS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $147,259 10,900
2026-03-31 $3,731,597 276,210
2026-03-31 $174,279 12,900
2025-12-31 $1,972,864 158,463
2025-09-30 $521,908 52,718
2025-06-30 $5,260,046 589,031
2024-09-30 $596,196 51,352
2024-03-31 $6,453,617 540,504
2023-03-31 $280,673 29,176
2023-03-31 $122,174 12,700
2023-03-31 $242,424 25,200
2022-09-30 $1,142,259 134,068
2022-03-31 $127,296 11,700
2021-12-31 $4,639,667 342,917
2021-12-31 $165,066 12,200
2021-09-30 $3,940,231 290,792
2021-06-30 $970,862 67,940
2021-03-31 $3,730,311 267,023
2020-12-31 $1,869,221 99,745